Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
BMC Pulm Med. 2023 Jul 10;23(1):250. doi: 10.1186/s12890-023-02543-z.
Bronchiectasis is a widely prevalent airway disease characterized by airway dilatation and recurrent infections, that can lead to respiratory failure in severe cases. The etiology of bronchiectasis varies geographically, but there is a lack of published data examining its etiology specifically within the Middle Eastern population.
We conducted a retrospective analysis of our bronchiectasis patient registry, extracting clinical and demographic characteristics from electronic medical records. Quantitative variables were presented as the median and interquartile range (IQR), while categorical variables were expressed as numbers and percentages. Statistical comparisons for continuous characteristics were performed using the t-test, and significance was determined by a p-value less than 0.05.
In total we analysed 260 records (63% female, 37% male), with median age of 58 years (interquartile range (IQR) 38-71), Body Mass Index (BMI) 25.8(IQR 22-30), forced expiratory volume in the first second (FEV1) %predicted 65 (IQR 43-79) and FEV1/forced vital capacity (FVC) 0.76 (0.67-0.86). Sixty-five cases (25%) were post-infectious in aetiology (excluding post-TB - n:27 10.4%). Forty-eight (18.5%) patients were labelled idiopathic, while Primary Ciliary Dyskinesia (PCD) accounted for 23 (8.8%) cases. Pseudomonas aeruginosa was the most common colonizing organism (32.7%), followed by Haemophilus influenzae (9.2%) and Methicillin-Sensitive Staphylococcus aureus(6.9%). At the time of review, 11 patients had died (median age, FEV %predicted, and bronchiectasis severity index (BSI) 59 years, 38% and 15.5 respectively), all due to respiratory failure, and as expected, all were classed severe on BSI. The BSI score was available for 109 patients, of which 31(28%) were classed mild, 29(27%) were moderate, and 49 (45%) were classed severe. The median BSI score was 8 (IQR 4-11). On dividing the patients according to obstructive vs. restrictive spirometry, we found that patients with FEV1/FVC < 0.70 had significantly higher BSI (10.1 vs. 6.9, p-value < 0.001) and that 8 out of the 11 deceased patients had FEV1/FVC < 70%.
In our study, post-infectious, idiopathic, and PCD were identified as the most common etiologies of bronchiectasis. Additionally, patients with obstructive spirometry appeared to have a worse prognosis compared to those with restrictive spirometry.
支气管扩张症是一种广泛流行的气道疾病,其特征为气道扩张和反复感染,在严重情况下可导致呼吸衰竭。支气管扩张症的病因在地理上有所不同,但缺乏专门针对中东人群病因的已发表数据。
我们对支气管扩张症患者的病历进行了回顾性分析,从电子病历中提取临床和人口统计学特征。定量变量以中位数和四分位距(IQR)表示,而分类变量则以数字和百分比表示。对于连续特征的统计比较采用 t 检验,显著性由 p 值小于 0.05 确定。
我们共分析了 260 份记录(63%为女性,37%为男性),中位年龄为 58 岁(IQR 38-71),体重指数(BMI)为 25.8(IQR 22-30),第一秒用力呼气量(FEV1)%预计值为 65(IQR 43-79),FEV1/用力肺活量(FVC)为 0.76(0.67-0.86)。65 例(25%)的病因是感染后(不包括结核后 - n:27 10.4%)。48 例(18.5%)患者被标记为特发性,而原发性纤毛运动障碍(PCD)占 23 例(8.8%)。铜绿假单胞菌是最常见的定植菌(32.7%),其次是流感嗜血杆菌(9.2%)和甲氧西林敏感金黄色葡萄球菌(6.9%)。在审查时,有 11 名患者死亡(中位年龄、FEV1%预计值和支气管扩张严重指数(BSI)分别为 59 岁、38%和 15.5),均因呼吸衰竭所致,而且所有患者在 BSI 上均被归类为严重。BSI 评分可用于 109 名患者,其中 31 名(28%)为轻度,29 名(27%)为中度,49 名(45%)为重度。BSI 的中位数为 8(IQR 4-11)。根据阻塞性与限制性肺量计检查将患者分组后,我们发现 FEV1/FVC<0.70 的患者 BSI 明显更高(10.1 比 6.9,p 值<0.001),且 11 名死亡患者中有 8 名 FEV1/FVC<70%。
在我们的研究中,感染后、特发性和 PCD 被确定为支气管扩张症的最常见病因。此外,与限制性肺量计检查相比,阻塞性肺量计检查的患者似乎预后更差。